跳至主要内容
临床试验/ITMCTR2100004989
ITMCTR2100004989招募中未知

Clinical Study on Guihuang Prescription in Treating Type III Prostatitis (damp heat and blood stasis syndrome)

Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 50(—)
性别
Male

入选标准

  • 1. Aged 18-50 years; ??
  • 2. Those who meet the diagnostic criteria of type III prostatitis in Western medicine;
  • 3. TCM syndrome differentiation in line with damp-heat stasis syndrome;
  • 4. The disease course exceeds 3 months;
  • 5. Those who have not received other treatments before treatment, those who have received treatment should stop taking the drug for at least 2 weeks;
  • 6. Those who signed the informed consent.

排除标准

  • 1. Allergic constitution, those who are allergic to this drug and those who cannot tolerate the drug;
  • 2. Combined with urethritis, acute prostatitis, urinary calculi, urethral stricture, prostate tumor and other diseases;
  • 3. Patients with severe cardiovascular disease, cerebrovascular disease, hypotension, liver and kidney insufficiency, hematopoietic system disease, and mental illness.

研究者

相似试验